Home › Funds › Distillate Capital Partners LLC › BSX
Distillate Capital Partners LLC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Distillate Capital Partners LLC reported holding 450,915 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$19.2M, representing 1.00% of its reported portfolio and ranking #36 among its reported holdings. Distillate Capital Partners LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Distillate Capital Partners LLC's BSX position evolved
Distillate Capital Partners LLC first disclosed a stake in BSX in Q2 2026 at 450,915 shares (US$19.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 450.92K | $19.25M | New |
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Distillate Capital Partners LLC
FAQ
How long has Distillate Capital Partners LLC held BSX?
Distillate Capital Partners LLC has disclosed BSX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Distillate Capital Partners LLC's current position in BSX?
As of Q2 2026, Distillate Capital Partners LLC holds 450.92K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $19.25M, representing 1.00% of its reported portfolio and ranking #36.
Has Distillate Capital Partners LLC been buying or selling BSX?
In the latest 13F filing (Q2 2026), Distillate Capital Partners LLC newly opened its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.